Skip to main content

Table 1 Results of the alignment

From: FusionSeq: a modular framework for finding gene fusions by analyzing paired-end RNA-sequencing data

Sample ID Type Known fusion type Read size (nt) Total number of PE reads Mapped PE reads Percentage of mapped PE reads
106_T PCa TMPRSS2-ERG 51 7,239,733 4,723,941 65.25%
1700_D PCa TMPRSS2-ERG 51 12,435,299 7,629,273 61.35%
580_B PCa TMPRSS2-ERG 36 18,134,550 7,690,673 42.41%
99_T PCa NDRG1-ERG 36 2,844,879 1,515,444 53.27%
2621_D PCa SLC45A3-ERG 54 22,079,700 11,899,984 53.90%
1043_D PCa No known fusions 51 3,003,305 1,898,332 63.21%
NCI-H660 PCa cell line TMPRSS2-ERG 51 6,512,688 4,120,365 63.27%
GM12878 Lymphoblastoid cell line No known fusions 54 44,829,991 20,676,159 46.12%
  1. Total number of PE reads, number of mapped PE reads and the percentage mapped are reported, Note that the number of single-end reads is double the number of PE reads. PCa, prostate cancer.